Advanced search
Publication Cover
Cancer Management and Research Volume 11, 2019 - Issue
Submit an article Journal homepage
139
Views
37
CrossRef citations to date
0
Altmetric
Original Research

Prognostic value of the 2018 FIGO staging system for cervical cancer patients with surgical risk factors

Ding-Ding Yan1 Department of Gynecologic Oncology, Zhejiang Cancer Hospital, Hangzhou, People’s Republic of China
,
Qiu Tang1 Department of Gynecologic Oncology, Zhejiang Cancer Hospital, Hangzhou, People’s Republic of ChinaCorrespondence[email protected]
,
Jian-Hong Chen1 Department of Gynecologic Oncology, Zhejiang Cancer Hospital, Hangzhou, People’s Republic of China
,
Ye-Qiang Tu1 Department of Gynecologic Oncology, Zhejiang Cancer Hospital, Hangzhou, People’s Republic of China
&
Xiao-Juan Lv1 Department of Gynecologic Oncology, Zhejiang Cancer Hospital, Hangzhou, People’s Republic of China
Pages 5473-5480 | Published online: 13 Jun 2019

References

  • Sedlis A, Bundy BN, Rotman MZ, Lentz SS, Muderspach LI, Zaino RJ. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study. Gynecol Oncol. 1999;73(2):177–183. doi:10.1006/gyno.1999.538710329031
  • Van de Putte G, Lie AK, Vach W, Baekelandt M, Kristensen GB. Risk grouping in stage IB squamous cell cervical carcinoma. Gynecol Oncol. 2005;99(1):106–112. doi:10.1016/j.ygyno.2005.05.02616137752
  • Ryu SY, Park SI, Nam BH, et al. Is adjuvant chemoradiotherapy overtreatment in cervical cancer patients with intermediate risk factors? Int J Radiat Oncol Biol Phys. 2011;79(3):794–799. doi:10.1016/j.ijrobp.2009.11.01920421158
  • Samlal RA, van der Velden J, Schilthuis MS, et al. Identification of high-risk groups among node-positive patients with stage IB and IIA cervical carcinoma. Gynecol Oncol. 1997;64(3):463–467.9062151
  • Inoue T, Okumura M. Prognostic significance of parametrial extension in patients with cervical carcinoma Stages IB, IIA, and IIB. A study of 628 cases treated by radical hysterectomy and lymphadenectomy with or without postoperative irradiation. Cancer. 1984;54(8):1714–1719.6478409
  • Quinn MA, Benedet JL, Odicino F, et al. Carcinoma of the Cervix Uteri. Int J Gynaecol Obstet. 2006;95 Suppl 1:S43–S103. doi:10.1016/S0020-7292(06)60030-1
  • Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri. Int J Gynaecol Obstet. 2018;143 Suppl 2:22–36. doi:10.1002/ijgo.1261130306584
  • Matsuo K, Machida H, Mandelbaum RS, Konishi I, Mikami M. Validation of the 2018 FIGO cervical cancer staging system. Gynecol Oncol. 2019;152(1):87–93. doi:10.1016/j.ygyno.2018.10.02630389105
  • Odicino F, Pecorelli S, Zigliani L, Creasman WT. History of the FIGO cancer staging system. Int J Gynaecol Obstet. 2008;101(2):205–210. doi:10.1016/j.ijgo.2007.11.00418199437
  • Noguchi H, Shiozawa I, Sakai Y, Yamazaki T, Fukuta T. Pelvic lymph node metastasis of uterine cervical cancer. Gynecol Oncol. 1987;27(2):150–158.3570054
  • Liu Y, Zhao LJ, Li MZ, Li MX, Wang JL, Wei LH. The number of positive pelvic lymph nodes and multiple groups of pelvic lymph node metastasis influence prognosis in stage IA-IIB cervical squamous cell carcinoma. Chin Med J. 2015;128(15):2084–2089. doi:10.4103/0366-6999.16137226228223
  • Berman ML, Keys H, Creasman W, DiSaia P, Bundy B, Blessing J. Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes (a Gynecologic Oncology Group study). Gynecol Oncol. 1984;19(1):8–16.6469092
  • Matsuo K, Grubbs BH, Mikami M. Quality and quantity metrics of pelvic lymph node metastasis and risk of para-aortic lymph node metastasis in stage IB-IIB cervical cancer. J Gynecol Oncol. 2018;29(1):e10. doi:10.3802/jgo.2018.29.e1029185268
  • Kim HS, Song YS. International Federation of Gynecology and Obstetrics (FIGO) staging system revised: what should be considered critically for gynecologic cancer? J Gynecol Oncol. 2009;20(3):135–136.19809545
  • Brockbank E, Kokka F, Bryant A, Pomel C, Reynolds K. Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer. Cochrane Database Syst Rev. 2013;(3):CD008217.23543561
  • Grigsby PW, Heydon K, Mutch DG, Kim RY, Eifel P. Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys. 2001;51(4):982–987.11704321
  • Gouy S, Morice P, Narducci F, et al. Prospective multicenter study evaluating the survival of patients with locally advanced cervical cancer undergoing laparoscopic para-aortic lymphadenectomy before chemoradiotherapy in the era of positron emission tomography imaging. J Clin Oncol. 2013;31(24):3026–3033. doi:10.1200/JCO.2012.47.352023857967
  • Inoue T, Morita K. The prognostic significance of number of positive nodes in cervical carcinoma Stages IB, IIA, and IIB. Cancer. 1990;65(9):1923–1927.2372764
  • Sakuragi N, Satoh C, Takeda N, et al. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with Stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy. Cancer. 1999;85(7):1547–1554.10193945
  • Takeda N, Sakuragi N, Takeda M, et al. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy. Acta Obstet Gynecol Scand. 2002;81(12):1144–1151.12519111

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.